back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-11-29 17:14 Tx date 2019-11-14 |
$PVOT
Pivot Pharmaceuticals Inc. |
Lucky, Chris S.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+250,000 vol |
250,000 | |
| Filed 2019-11-29 17:12 Tx date 2019-07-02 |
$PVOT
Pivot Pharmaceuticals Inc. |
Lucky, Chris S.
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-29 17:10 Tx date 2019-07-02 |
$PVOT
Pivot Pharmaceuticals Inc. |
Lucky, Chris S.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+250,000 vol $0.39 each |
250,000 | |
| Filed 2019-11-29 17:09 Tx date 2019-07-02 |
$PVOT
Pivot Pharmaceuticals Inc. |
Lucky, Chris S.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-22 09:40 Tx date 2019-10-01 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
750,000 | ||
| Filed 2019-11-22 09:39 Tx date 2019-11-20 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
+1,500,000 vol |
3,000,000 | |
| Filed 2019-11-22 09:36 Tx date 2019-11-22 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+20,000 vol $0.14 each |
1,517,500 | |
| Filed 2019-11-20 11:14 Tx date 2019-11-20 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+20,000 vol $0.125 each |
1,497,500 | |
| Filed 2019-11-19 19:36 Tx date 2019-09-04 |
$PVOT
Pivot Pharmaceuticals Inc. |
Rinow, Toni
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$267,750
+850,000 vol $0.315 each |
850,000 | |
| Filed 2019-11-19 19:34 Tx date 2019-09-04 |
$PVOT
Pivot Pharmaceuticals Inc. |
Rinow, Toni
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-18 11:03 Tx date 2019-11-14 |
$PVOT
Pivot Pharmaceuticals Inc. |
Toth, Krisztian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500,000 vol |
2,500,000 | |
| Filed 2019-11-18 11:02 Tx date 2019-05-31 |
$PVOT
Pivot Pharmaceuticals Inc. |
Toth, Krisztian
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-11-15 15:23 Tx date 2019-11-12 |
$PVOT
Pivot Pharmaceuticals Inc. |
Renz, Wolfgang
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+165,000 vol |
365,000 | |
| Filed 2019-11-13 14:58 Tx date 2019-11-13 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,025
+15,000 vol $0.135 each |
1,477,500 | |
| Filed 2019-11-13 06:48 Tx date 2019-11-07 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,175
+15,000 vol $0.145 each |
1,462,500 | |
| Filed 2019-11-12 15:29 Tx date 2019-11-07 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+15,000 vol |
||
| Filed 2019-11-12 15:29 Tx date 2019-11-07 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+15,000 vol |
1,462,500 | |
| Filed 2019-10-18 17:04 Tx date 2019-10-16 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$925.00
+5,000 vol $0.185 each |
2,347,384 | |
| Filed 2019-10-18 17:03 Tx date 2019-10-16 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+50,000 vol $0.19 each |
2,342,384 | |
| Filed 2019-10-15 18:56 Tx date 2019-10-15 |
$PVOT
Pivot Pharmaceuticals Inc. |
Starr, James Russell Nelles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+200,000 vol |
1,447,500 |